Effect of sinomenine on the proportion of T helper cells 17 and Regulatory T cells in peripheral blood mononuclear cells from patients with rheumatoid arthritis

LI Ning,DENG Yun,ZHOU Jieru,SONG Guangzhu,WANG Jiayi,SHEN Yi,ZHANG Jie,HAN Jie

2013-01-01

Abstract:Objective To investigate the effect of sinomenine on the proportion of T helper cells 17 (Th17) and Regulatory T cells (Tregs) and to explore the mechanism of sinomenine for the treatment of rheumatoid arthritis. Methods Peripheral venous blood (20 mL) was collected from 40 patients with rheumatoid arthritis (20 treated with sinomenine and 20 treated with diclofenac sodium) and 40 healthy volunteers before treatment and at 12 weeks after treatment. Heparin sodium was used for anticoagulation. The peripheral blood mononuclear cells were isolated by Ficoll density gradient centrifugation and labeled with fluorescent antibodies. The number of Th17 (CD4+IL-17+) and Treg (CD4+CD25+CD127lowFoxP3+) was measured by flow cytometry. Rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), C reactive protein (CRP), cyclic citrulline peptide (CCP) antibody and Disease Activity Score (DAS) were compared between sinomenine group and diclofenac group. The proportion of Th17/Tregs was analyzed. Results The clinical parameters, such as CRP, ESR, RF, and CCP level were all significantly decreased after treatment with sinomenine or diclofenac sodium (P<0.05, 0.01). The parameters in the sinomenine group were even lower than those in the diclofenac group, but the difference was not statistically significant (all P>0.05). DAS28 score was significantly reduced after treatment with sinomenine or diclofenac sodium (P<0.05), and there was significant difference between the two treatment groups (P<0.05). Before treatment, the proportion of Th17 in the two treatment groups were significantly higher than that in control group (P<0.05). The proportion of Th17 after treatment with sinomenine or diclofenac sodium was significantly lower than before treatment (P<0.05), and that in the sinomenine group was even lower than diclofenac group (P<0.05). Before treatment, the proportion of Treg in the two treatment groups were significantly lower than that in control group (all P<0.01). The proportion of Treg was elevated after treatment with sinomenine (P<0.01). There was no significant difference in the proportion of Treg before and after treatment with diclofenac sodium (P>0.05), but there was significant difference between two treatment groups (P<0.01). Conclusion The therapeutic effect of sinomenine on rheumatoid arthritis may be related to inhibiting proinflammatory Th17 and promoting immunosuppressive Treg.